Literature DB >> 19052996

[The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study].

H Geldmacher1, H Biller, A Herbst, K Urbanski, M Allison, A S Buist, J M Hohlfeld, T Welte.   

Abstract

BACKGROUND AND
OBJECTIVE: Chronic obstructive pulmonary disease (COPD) is one of the most common causes of chronic morbidity and mortality. The "Burden of Obstructive Lung Disease" (BOLD) initiative was established as an international study collecting data about the prevalence of COPD. The Medical University of Hanover took part in this study collecting data representative for Germany.
METHODS: 683 individuals aged = 40 years from the city and region of Hannover were included in the study. On the basis of standardized questionnaires data were collected on general health, physical and mental capability, smoking habits and occupational exposure to dust. All participants performed spirometry before and after inhalation of salbutamol.
RESULTS: The prevalence of COPD, GOLD (Global Health Initiative on Obstructive Lung Disease) severity stage = I, was 13.2% (GOLD stage I: 7.4%; GOLD stage II: 5.0%, GOLD stage III or IV: 0.8%). There was a marked increase of the prevalence of COPD depending on age and smoking habits. The percentage of active smokers in the sample was 20.6 %. Among younger participants the percentage of female smokers was noticeable higher than in older subjects. Although clinical symptoms of COPD, GOLD stage = III correlated with disease severity, only persons with COPD reported reduced physical capability.
CONCLUSION: COPD is a highly prevalent disease. With regard to the increasing life expectancy and the change of smoking habits of the population, a further increase of morbidity and mortality due to COPD must be expected, especially in women.

Entities:  

Mesh:

Year:  2008        PMID: 19052996     DOI: 10.1055/s-0028-1105858

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  22 in total

1.  [Chronic obstructive lung disease. A growing problem in intensive care medicine].

Authors:  T Welte
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-04       Impact factor: 0.840

2.  Chronic obstructive pulmonary disease- a growing cause of death and disability worldwide.

Authors:  Tobias Welte
Journal:  Dtsch Arztebl Int       Date:  2014-12-05       Impact factor: 5.594

Review 3.  Endoscopic volume reduction in COPD- a critical review.

Authors:  Daniela Gompelmann; Ralf Eberhardt; Felix Herth
Journal:  Dtsch Arztebl Int       Date:  2014-12-05       Impact factor: 5.594

Review 4.  The diagnosis of chronic obstructive pulmonary disease.

Authors:  Rainer Burkhardt; Wulf Pankow
Journal:  Dtsch Arztebl Int       Date:  2014-12-05       Impact factor: 5.594

5.  Medical Treatment of COPD.

Authors:  Jana Graf; Rudolf A Jörres; Tanja Lucke; Dennis Nowak; Claus F Vogelmeier; Joachim H Ficker
Journal:  Dtsch Arztebl Int       Date:  2018-09-14       Impact factor: 5.594

6.  Health-related quality of life in patients with severe COPD hospitalized for exacerbations - comparing EQ-5D, SF-12 and SGRQ.

Authors:  Petra Menn; Norbert Weber; Rolf Holle
Journal:  Health Qual Life Outcomes       Date:  2010-04-15       Impact factor: 3.186

7.  Lobar lung resection in elderly patients with non-small cell lung carcinoma: impact of chronic obstructive pulmonary disease on surgical outcome.

Authors:  O Senbaklavaci
Journal:  Int Surg       Date:  2014 Jul-Aug

8.  [Pulmonary function in elderly subjects with metabolic syndrome and type II diabetes : Data from the Berlin Aging Study II].

Authors:  Nikolaus Buchmann; Kristina Norman; Elisabeth Steinhagen-Thiessen; Ilja Demuth; Rahel Eckardt
Journal:  Z Gerontol Geriatr       Date:  2015-10-27       Impact factor: 1.281

9.  [Chronic obstructive pulmonary disease : new pharmacotherapeutic options].

Authors:  T Greulich; A R Koczulla; C Vogelmeier
Journal:  Internist (Berl)       Date:  2012-11       Impact factor: 0.743

10.  Factors associated with generic health-related quality of life (HRQOL) in patients with chronic obstructive pulmonary disease (COPD): a cross-sectional study.

Authors:  Magdalena Brandl; Merle M Böhmer; Susanne Brandstetter; Tamara Finger; Wiebke Fischer; Michael Pfeifer; Christian Apfelbacher
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.